[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

EMEA (Europe, Middle East and Africa) Dermatology OTC medications Market Report 2017

January 2018 | 118 pages | ID: E9E297103A7EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Dermatology OTC medications market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Dermatology OTC medications for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Dermatology OTC medications market competition by top manufacturers/players, with Dermatology OTC medications sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Beiersdorf
  • Lancaster Beauty
  • loreal
  • Johnson & Johnson
  • Obagi Medical Products
  • Bayer
  • Shiseido
  • Amway
  • Avon Products
  • Clarins
  • Edgewell Personal Care
  • Lotus Herbals
  • Proctor & Gamble
  • Revlon
  • COOLA SUNCARE
  • Sebapharma
  • Clinique Laboratories
  • Sisley Paris
  • Avene
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Sun screens
  • Anti-aging
  • Wrinkle cream
  • Acne Treatment
  • others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • male
  • female
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Dermatology OTC medications Market Report 2017

1 DERMATOLOGY OTC MEDICATIONS OVERVIEW

1.1 Product Overview and Scope of Dermatology OTC medications
1.2 Classification of Dermatology OTC medications
  1.2.1 EMEA Dermatology OTC medications Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Dermatology OTC medications Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Sun screens
  1.2.4 Anti-aging
  1.2.5 Wrinkle cream
  1.2.6 Acne Treatment
  1.2.7 others
1.3 EMEA Dermatology OTC medications Market by Application/End Users
  1.3.1 EMEA Dermatology OTC medications Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 male
  1.3.3 female
1.4 EMEA Dermatology OTC medications Market by Region
  1.4.1 EMEA Dermatology OTC medications Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Dermatology OTC medications (2012-2022)
  1.5.1 EMEA Dermatology OTC medications Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Dermatology OTC medications Revenue and Growth Rate (2012-2022)

2 EMEA DERMATOLOGY OTC MEDICATIONS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Dermatology OTC medications Market Competition by Players/Manufacturers
  2.1.1 EMEA Dermatology OTC medications Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Dermatology OTC medications Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Dermatology OTC medications Sale Price by Players (2012-2017)
2.2 EMEA Dermatology OTC medications (Volume and Value) by Type/Product Category
  2.2.1 EMEA Dermatology OTC medications Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Dermatology OTC medications Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Dermatology OTC medications Sale Price by Type (2012-2017)
2.3 EMEA Dermatology OTC medications (Volume) by Application
2.4 EMEA Dermatology OTC medications (Volume and Value) by Region
  2.4.1 EMEA Dermatology OTC medications Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Dermatology OTC medications Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Dermatology OTC medications Sales Price by Region (2012-2017)

3 EUROPE DERMATOLOGY OTC MEDICATIONS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Dermatology OTC medications Sales and Value (2012-2017)
  3.1.1 Europe Dermatology OTC medications Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Dermatology OTC medications Revenue and Growth Rate (2012-2017)
3.2 Europe Dermatology OTC medications Sales and Market Share by Type
3.3 Europe Dermatology OTC medications Sales and Market Share by Application
3.4 Europe Dermatology OTC medications Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Dermatology OTC medications Sales Volume by Countries (2012-2017)
  3.4.2 Europe Dermatology OTC medications Revenue by Countries (2012-2017)
  3.4.3 Germany Dermatology OTC medications Sales and Growth Rate (2012-2017)
  3.4.4 France Dermatology OTC medications Sales and Growth Rate (2012-2017)
  3.4.5 UK Dermatology OTC medications Sales and Growth Rate (2012-2017)
  3.4.6 Russia Dermatology OTC medications Sales and Growth Rate (2012-2017)
  3.4.7 Italy Dermatology OTC medications Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Dermatology OTC medications Sales and Growth Rate (2012-2017)

4 MIDDLE EAST DERMATOLOGY OTC MEDICATIONS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Dermatology OTC medications Sales and Value (2012-2017)
  4.1.1 Middle East Dermatology OTC medications Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Dermatology OTC medications Revenue and Growth Rate (2012-2017)
4.2 Middle East Dermatology OTC medications Sales and Market Share by Type
4.3 Middle East Dermatology OTC medications Sales and Market Share by Application
4.4 Middle East Dermatology OTC medications Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Dermatology OTC medications Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Dermatology OTC medications Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Dermatology OTC medications Sales and Growth Rate (2012-2017)
  4.4.4 Israel Dermatology OTC medications Sales and Growth Rate (2012-2017)
  4.4.5 UAE Dermatology OTC medications Sales and Growth Rate (2012-2017)
  4.4.6 Iran Dermatology OTC medications Sales and Growth Rate (2012-2017)

5 AFRICA DERMATOLOGY OTC MEDICATIONS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Dermatology OTC medications Sales and Value (2012-2017)
  5.1.1 Africa Dermatology OTC medications Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Dermatology OTC medications Revenue and Growth Rate (2012-2017)
5.2 Africa Dermatology OTC medications Sales and Market Share by Type
5.3 Africa Dermatology OTC medications Sales and Market Share by Application
5.4 Africa Dermatology OTC medications Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Dermatology OTC medications Sales Volume by Countries (2012-2017)
  5.4.2 Africa Dermatology OTC medications Revenue by Countries (2012-2017)
  5.4.3 South Africa Dermatology OTC medications Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Dermatology OTC medications Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Dermatology OTC medications Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Dermatology OTC medications Sales and Growth Rate (2012-2017)

6 EMEA DERMATOLOGY OTC MEDICATIONS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Beiersdorf
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Dermatology OTC medications Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Beiersdorf Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Lancaster Beauty
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Dermatology OTC medications Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Lancaster Beauty Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 loreal
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Dermatology OTC medications Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 loreal Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Dermatology OTC medications Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Obagi Medical Products
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Dermatology OTC medications Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Obagi Medical Products Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bayer
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Dermatology OTC medications Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bayer Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Shiseido
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Dermatology OTC medications Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Shiseido Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Amway
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Dermatology OTC medications Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Amway Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Avon Products
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Dermatology OTC medications Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Avon Products Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Clarins
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Dermatology OTC medications Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Clarins Dermatology OTC medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Edgewell Personal Care
6.12 Lotus Herbals
6.13 Proctor & Gamble
6.14 Revlon
6.15 COOLA SUNCARE
6.16 Sebapharma
6.17 Clinique Laboratories
6.18 Sisley Paris
6.19 Avene

7 DERMATOLOGY OTC MEDICATIONS MANUFACTURING COST ANALYSIS

7.1 Dermatology OTC medications Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dermatology OTC medications

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Dermatology OTC medications Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dermatology OTC medications Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA DERMATOLOGY OTC MEDICATIONS MARKET FORECAST (2017-2022)

11.1 EMEA Dermatology OTC medications Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Dermatology OTC medications Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Dermatology OTC medications Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Dermatology OTC medications Price and Trend Forecast (2017-2022)
11.2 EMEA Dermatology OTC medications Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Dermatology OTC medications Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Dermatology OTC medications Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Dermatology OTC medications Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Dermatology OTC medications Sales Forecast by Type (2017-2022)
11.7 EMEA Dermatology OTC medications Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Dermatology OTC medications
Figure EMEA Dermatology OTC medications Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Dermatology OTC medications Sales Volume Market Share by Type (Product Category) in 2016
Figure Sun screens Product Picture
Figure Anti-aging Product Picture
Figure Wrinkle cream Product Picture
Figure Acne Treatment Product Picture
Figure others Product Picture
Figure EMEA Dermatology OTC medications Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Dermatology OTC medications by Application in 2016
Figure male Examples
Table Key Downstream Customer in male
Figure female Examples
Table Key Downstream Customer in female
Figure EMEA Dermatology OTC medications Market Size (Million USD) by Region (2012-2022)
Figure Europe Dermatology OTC medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Dermatology OTC medications Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Dermatology OTC medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Dermatology OTC medications Revenue (Million USD) Status and Forecast by Countries
Figure Africa Dermatology OTC medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Dermatology OTC medications Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Dermatology OTC medications Sales Volume and Growth Rate (2012-2022)
Figure EMEA Dermatology OTC medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Dermatology OTC medications Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Dermatology OTC medications Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Dermatology OTC medications Sales Share by Players (2012-2017)
Figure 2016 Dermatology OTC medications Sales Share by Players
Figure 2017 Dermatology OTC medications Sales Share by Players
Figure EMEA Dermatology OTC medications Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Dermatology OTC medications Revenue (Million USD) by Players (2012-2017)
Table EMEA Dermatology OTC medications Revenue Share by Players (2012-2017)
Table 2016 EMEA Dermatology OTC medications Revenue Share by Players
Table 2017 EMEA Dermatology OTC medications Revenue Share by Players
Table EMEA Dermatology OTC medications Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Dermatology OTC medications Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Dermatology OTC medications Sales Share by Type (2012-2017)
Figure Sales Market Share of Dermatology OTC medications by Type (2012-2017)
Figure EMEA Dermatology OTC medications Sales Market Share by Type (2012-2017)
Table EMEA Dermatology OTC medications Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Dermatology OTC medications Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Dermatology OTC medications by Type in 2016
Table EMEA Dermatology OTC medications Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Dermatology OTC medications Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Dermatology OTC medications Sales Share by Application (2012-2017)
Figure Sales Market Share of Dermatology OTC medications by Application (2012-2017)
Figure EMEA Dermatology OTC medications Sales Market Share by Application in 2016
Table EMEA Dermatology OTC medications Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Dermatology OTC medications Sales Share by Region (2012-2017)
Figure Sales Market Share of Dermatology OTC medications by Region (2012-2017)
Figure EMEA Dermatology OTC medications Sales Market Share in 2016
Table EMEA Dermatology OTC medications Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Dermatology OTC medications Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Dermatology OTC medications by Region (2012-2017)
Figure EMEA Dermatology OTC medications Revenue Market Share Regions in 2016
Table EMEA Dermatology OTC medications Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Dermatology OTC medications Revenue and Growth Rate (2012-2017)
Table Europe Dermatology OTC medications Sales (K Units) by Type (2012-2017)
Table Europe Dermatology OTC medications Market Share by Type (2012-2017)
Figure Europe Dermatology OTC medications Market Share by Type in 2016
Table Europe Dermatology OTC medications Sales (K Units) by Application (2012-2017)
Table Europe Dermatology OTC medications Market Share by Application (2012-2017)
Figure Europe Dermatology OTC medications Market Share by Application in 2016
Table Europe Dermatology OTC medications Sales (K Units) by Countries (2012-2017)
Table Europe Dermatology OTC medications Sales Market Share by Countries (2012-2017)
Figure Europe Dermatology OTC medications Sales Market Share by Countries (2012-2017)
Figure Europe Dermatology OTC medications Sales Market Share by Countries in 2016
Table Europe Dermatology OTC medications Revenue (Million USD) by Countries (2012-2017)
Table Europe Dermatology OTC medications Revenue Market Share by Countries (2012-2017)
Figure Europe Dermatology OTC medications Revenue Market Share by Countries (2012-2017)
Figure Europe Dermatology OTC medications Revenue Market Share by Countries in 2016
Figure Germany Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure France Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure UK Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Dermatology OTC medications Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Dermatology OTC medications Sales (K Units) by Type (2012-2017)
Table Middle East Dermatology OTC medications Market Share by Type (2012-2017)
Figure Middle East Dermatology OTC medications Market Share by Type (2012-2017)
Table Middle East Dermatology OTC medications Sales (K Units) by Applications (2012-2017)
Table Middle East Dermatology OTC medications Market Share by Applications (2012-2017)
Figure Middle East Dermatology OTC medications Sales Market Share by Application in 2016
Table Middle East Dermatology OTC medications Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Dermatology OTC medications Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Dermatology OTC medications Sales Volume Market Share by Countries in 2016
Table Middle East Dermatology OTC medications Revenue (Million USD) by Countries (2012-2017)
Table Middle East Dermatology OTC medications Revenue Market Share by Countries (2012-2017)
Figure Middle East Dermatology OTC medications Revenue Market Share by Countries (2012-2017)
Figure Middle East Dermatology OTC medications Revenue Market Share by Countries in 2016
Figure Saudi Arabia Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Dermatology OTC medications Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Dermatology OTC medications Sales (K Units) by Type (2012-2017)
Table Africa Dermatology OTC medications Sales Market Share by Type (2012-2017)
Figure Africa Dermatology OTC medications Sales Market Share by Type (2012-2017)
Figure Africa Dermatology OTC medications Sales Market Share by Type in 2016
Table Africa Dermatology OTC medications Sales (K Units) by Application (2012-2017)
Table Africa Dermatology OTC medications Sales Market Share by Application (2012-2017)
Figure Africa Dermatology OTC medications Sales Market Share by Application (2012-2017)
Table Africa Dermatology OTC medications Sales Volume (K Units) by Countries (2012-2017)
Table Africa Dermatology OTC medications Sales Market Share by Countries (2012-2017)
Figure Africa Dermatology OTC medications Sales Market Share by Countries (2012-2017)
Figure Africa Dermatology OTC medications Sales Market Share by Countries in 2016
Table Africa Dermatology OTC medications Revenue (Million USD) by Countries (2012-2017)
Table Africa Dermatology OTC medications Revenue Market Share by Countries (2012-2017)
Figure Africa Dermatology OTC medications Revenue Market Share by Countries (2012-2017)
Figure Africa Dermatology OTC medications Revenue Market Share by Countries in 2016
Figure South Africa Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Table Beiersdorf Dermatology OTC medications Basic Information List
Table Beiersdorf Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beiersdorf Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Beiersdorf Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure Beiersdorf Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table Lancaster Beauty Dermatology OTC medications Basic Information List
Table Lancaster Beauty Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lancaster Beauty Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Lancaster Beauty Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure Lancaster Beauty Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table loreal Dermatology OTC medications Basic Information List
Table loreal Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure loreal Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure loreal Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure loreal Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Dermatology OTC medications Basic Information List
Table Johnson & Johnson Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table Obagi Medical Products Dermatology OTC medications Basic Information List
Table Obagi Medical Products Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Obagi Medical Products Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Obagi Medical Products Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure Obagi Medical Products Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table Bayer Dermatology OTC medications Basic Information List
Table Bayer Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure Bayer Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table Shiseido Dermatology OTC medications Basic Information List
Table Shiseido Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shiseido Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Shiseido Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure Shiseido Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table Amway Dermatology OTC medications Basic Information List
Table Amway Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amway Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Amway Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure Amway Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table Avon Products Dermatology OTC medications Basic Information List
Table Avon Products Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Avon Products Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Avon Products Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure Avon Products Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table Clarins Dermatology OTC medications Basic Information List
Table Clarins Dermatology OTC medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Clarins Dermatology OTC medications Sales (K Units) and Growth Rate (2012-2017)
Figure Clarins Dermatology OTC medications Sales Market Share in EMEA (2012-2017)
Figure Clarins Dermatology OTC medications Revenue Market Share in EMEA (2012-2017)
Table Edgewell Personal Care Dermatology OTC medications Basic Information List
Table Lotus Herbals Dermatology OTC medications Basic Information List
Table Proctor & Gamble Dermatology OTC medications Basic Information List
Table Revlon Dermatology OTC medications Basic Information List
Table COOLA SUNCARE Dermatology OTC medications Basic Information List
Table Sebapharma Dermatology OTC medications Basic Information List
Table Clinique Laboratories Dermatology OTC medications Basic Information List
Table Sisley Paris Dermatology OTC medications Basic Information List
Table Avene Dermatology OTC medications Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermatology OTC medications
Figure Manufacturing Process Analysis of Dermatology OTC medications
Figure Dermatology OTC medications Industrial Chain Analysis
Table Raw Materials Sources of Dermatology OTC medications Major Manufacturers in 2016
Table Major Buyers of Dermatology OTC medications
Table Distributors/Traders List
Figure EMEA Dermatology OTC medications Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Dermatology OTC medications Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Dermatology OTC medications Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Dermatology OTC medications Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Dermatology OTC medications Sales Market Share Forecast by Region (2017-2022)
Table EMEA Dermatology OTC medications Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Dermatology OTC medications Revenue Market Share Forecast by Region (2017-2022)
Table Europe Dermatology OTC medications Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Dermatology OTC medications Sales Market Share Forecast by Countries (2017-2022)
Table Europe Dermatology OTC medications Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Dermatology OTC medications Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Dermatology OTC medications Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Dermatology OTC medications Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Dermatology OTC medications Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Dermatology OTC medications Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Dermatology OTC medications Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Dermatology OTC medications Sales Market Share Forecast by Countries (2017-2022)
Table Africa Dermatology OTC medications Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Dermatology OTC medications Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Dermatology OTC medications Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Dermatology OTC medications Sales Market Share Forecast by Type (2017-2022)
Table EMEA Dermatology OTC medications Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Dermatology OTC medications Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications